BiotechTube
Home/Roivant Sciences/Eric Valeur
EV

Eric Valeur

Vice President, Head of Drug Discovery

Roivant Sciences

Therapeutic Areas

Autoimmune DiseasesPulmonary DiseasesDermatology

Roivant Sciences Pipeline

DrugIndicationPhase
BrepocitinibDermatomyositisPhase 3
IMVT-1402Autoimmune Diseases (e.g., Thyroid Eye Disease, Myasthenia Gravis)Phase 2/3
MosliciguatPulmonary Diseases (e.g., PAH)Phase 2
VTAMA® (tapinarof)Plaque PsoriasisApproved

Leadership Team at Roivant Sciences

MG
Matt Gline
Chief Executive Officer
AG
Alex Gasner
EVP, Roivant Health
DG
Daniel Gold
Director
View full Roivant Sciences profile